Adapting Biotech Leadership Across Development and Therapies
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Adapting Biotech Leadership Across Development and Therapies
-
Narrated by:
-
By:
About this listen
Biotech leaders are asked to do a lot; move fast, manage limited resources, and guide teams through very different stages of development. In this episode of The Emerging Biotech Leader, host Kim Kushner talks with Dr. Benit Maru, Senior Vice President at SSI Strategy, about what it really looks like to lead in that environment.
They cover:
- The contrasts between early and late development leadership, and why those transitions can feel like two different roles
- How scenario planning and structured conversations help teams prepare for uncertainty
- Why documents like the clinical development plan or target product profile should be seen as living tools, not paper exercises
- The similarities and differences in leading across modalities—devices, biologics, and advanced therapies like cell and gene
- The importance of team dynamics, culture, and knowing when to bring in outside expertise
This episode is full of practical takeaways for biotech leaders who want to keep their strategies sound, their teams aligned, and their programs moving forward under pressure.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.